NL-OMON26607尚未招募不适用
A randomized, double-blind, placebo-controlled, single dose, 3-way cross-over study in healthy elderly subjects to develop an anti-cholinergic pharmacological challenge with biperiden
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Elderly male or female subjects aged between 65 and 80 (inclusive) years old;
- •2.Healthy subjects as defined by the absence of evidence of any clinically relevant active or chronic disease following detailed medical and surgical history review and a complete physical examination including vital signs, 12-lead ECG, haematology, blood chemistry, and urinalysis;
排除标准
- •1.Clinically relevant history of abnormal physical or mental health interfering with the study as determined from the medical history review and the physical examinations obtained during the screening visit and/or at the start of the first study day for each period as judged by the investigator (including (but not limited to), neurological, psychiatric, endocrine, cardiovascular (including recent myocardial infarction), respiratory, gastrointestinal, hepatic, renal disorder or presence of narrow-angle glaucoma).
- •2.History or clinical evidence of any disease and/or existence of any surgical or medical condition which might interfere with the absorption, distribution, metabolism or excretion of the study drugs.
研究者
相似试验
未知
Unknown
A single intravenous dose study of E3112 in Japanese healthy adult male subjectsHealthy Adult SubjectsJPRN-jRCT2080223364EA Pharma Co.,Ltd.40
进行中（未招募）
1 期
The pain reduction effects of different doses of Lopain (MTX-071) relative to placebo are evaluated in patients with chronic osteoarthritic knee joint pain.chronic osteoarthritic knee joint painMedDRA version: 21.1Level: LLTClassification code 10023476Term: Knee osteoarthritisSystem Organ Class: 100000004859MedDRA version: 20.0Level: LLTClassification code 10003244Term: Arthritic painsSystem Organ Class: 100000004859MedDRA version: 20.0Level: LLTClassification code 10064238Term: GonalgiaSystem Organ Class: 100000004859EUCTR2018-000818-37-HRMestex AG156
已完成
不适用
Phase I Clinical Study to Evauate the Tolerability and Pharmacokinetics of Belviq in Healthy Korean volunteersKCT0001063Ildong pharmaceutical24
已完成
不适用
A randomized, double-blind, placebo-controlled, single ascending dose and multiple dose study to evaluate the safety, tolerability and pharmacokinetics of Cannabidiol (GWP42003-P) oral liquid formulation with an open label two-period cross-over part to study food effects in healthy subjectsEpilepsyNL-OMON42686GW Research Ltd.56
进行中（未招募）
1 期
A trial to evaluate the safety, tolerability, and pharmacokinetics of AQ280 in healthy subjectsAllergic reaction in the gulletDigestive Systemeosinophilic esophagitis (EoE)ISRCTN14453297Aqilion AB64